Invesaro

Stocks Health care MNOV

NASDAQ · Health care

Medicinova Inc (MNOV)

It posted a net loss of $10.8M. In fiscal 2025 capital spending exceeded operating cash flow by $9.8M. At June 30, 2026 it held $25.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

What Medicinova Inc does

Medicinova Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MNOV.

Revenue and profit by year

Revenue
FY21: $4M $4M FY21FY23: $1M $1M FY23FY25: $409.7K $409.7K FY25
Net income
FY18: -$14.7M -$14.7M FY18FY19: -$12.9M -$12.9M FY19FY20: -$13.9M -$13.9M FY20FY21: -$10.1M -$10.1M FY21FY22: -$14.1M -$14.1M FY22FY23: -$8.6M -$8.6M FY23FY24: -$11M -$11M FY24FY25: -$12M -$12M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$409.7K-$13.3M-$12M-$0.24-$9.8M
2024n/a-$12.7M-$11M-$0.23-$10.6M
2023$1M-$9.9M-$8.6M-$0.17-$7.5M
2022n/a-$14.6M-$14.1M-$0.29-$12.9M
2021$4M-$10.2M-$10.1M-$0.21-$9.4M
2020n/a-$14.2M-$13.9M-$0.31-$10.9M

Latest SEC filings

What Medicinova Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 2, 2026
  2. August 19, 2026
  3. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. June 24, 2026
  5. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026
  6. April 29, 2026
  7. April 29, 2026
  8. April 29, 2026
  9. April 20, 2026
  10. April 17, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 25, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about MNOV

What does Medicinova Inc do?

Medicinova Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MNOV.

Is Medicinova Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $10.8M.

When did Medicinova Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement ended from September 2, 2026.

Similar companies

Follow MNOV

Get an email when Medicinova Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow MNOV: get an email when it files

Where the numbers come from

Financial figures are the values Medicinova Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.